A Paired Double Blind Randomised Comparison of Cavilon Durable Barrier Cream (CDBC) to 10% Glycerine (“Sorbolene”) Cream in the Prophylactic Management of Post-Mastectomy Irradiation Skin Care.

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Clinical Trial Registration

Related Post

26 November, 2025

TROG Member Prof Paul Keall’s innovative research recognised in two Premier’s Awards

LATEST NEWS; 26 November 2025 Medical physics researcher and

25 November, 2025

Automated quality assurance tool shows promise in TROG 18.01 NINJA trial

LATEST NEWS: 25 November 2025 Vital quality assurance (QA)